February 24, 2026

Surgery Partners, Inc. (SGRY): Growth Potential with a 64% Upside and Strong Buy Ratings

Surgery Partners, Inc. (NASDAQ: SGRY) is garnering significant attention from investors, fueled by promising analyst ratings and a compelling potential upside. Operating within the dynamic healthcare..

Ocular Therapeutix, Inc. (OCUL) Investor Outlook: A Biotech with a 205% Potential Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a key player in the biotechnology sector focusing on innovative ocular therapies, is capturing investor attention with a compelling potential upside..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Promising Biotech with Nearly 50% Upside Potential

Apogee Therapeutics, Inc. (NASDAQ: APGE) has captured the attention of investors with its robust pipeline in the biotechnology sector, focusing on innovative treatments for various inflammatory..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 33% Potential Upside in Diagnostics Innovation

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare diagnostics sector, offers an intriguing investment proposition with a notable 33.33% potential upside. As a diagnostics..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 40.97% Potential Upside for Investors

Innoviva, Inc. (NASDAQ: INVA), a biotechnology company rooted in the healthcare sector, is catching the eye of investors due to its promising potential upside. With a..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring a 72.96% Potential Upside in the Biotech Innovator

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneering biotechnology firm based in Cambridge, Massachusetts, is capturing investor attention with a staggering potential upside of 72.96%. Specializing in..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: A Healthcare Innovator with 28.58% Potential Upside

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands out in the healthcare sector with its innovative approach to non-opioid pain management. Headquartered in Brisbane, California, Pacira is at..

Twist Bioscience Corporation (TWST) Stock Analysis: Navigating a 16.9% Revenue Growth Amidst a Challenging Market

Twist Bioscience Corporation (NASDAQ: TWST) stands at the forefront of the synthetic DNA industry, offering a unique portfolio of products that cater to various sectors, including..

Adaptive Biotechnologies (ADPT) Stock Analysis: Exploring a 35% Upside Potential in Biotechnology

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a prominent player in the healthcare sector, is capturing the attention of investors with its promising growth potential and a notable..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unlocking a Potential 58% Upside

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a prominent player in the biotechnology sector, is making waves with its innovative approach to precision medicine oncology. With a robust..

Belite Bio, Inc (BLTE) Stock Analysis: A Glimpse into the Biotech’s 3.43% Potential Upside

Belite Bio, Inc (BLTE), a burgeoning name in the biotechnology sector, has caught the attention of investors with its innovative approach to tackling retinal degenerative diseases...

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 48.59% Potential Upside in the Healthcare Sector

Pulse Biosciences, Inc. (NASDAQ: PLSE), a burgeoning player in the healthcare sector, specifically within the Medical Instruments & Supplies industry, is capturing investor interest with a..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Navigating the Healthcare Sector with a 2.30% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is a noteworthy name in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.92..

NovoCure Limited (NVCR) Investor Outlook: Exploring a Potential 129.64% Upside

For investors seeking opportunities in the healthcare sector, NovoCure Limited (NASDAQ: NVCR) presents a compelling case with its oncology-focused innovations and a significant potential upside of..

Dyne Therapeutics (DYN) Stock Analysis: Exploring a 153% Potential Upside in the Biotech Arena

Investors seeking opportunities in the biotechnology sector should take a closer look at Dyne Therapeutics, Inc. (NASDAQ: DYN), a promising clinical-stage company focused on developing therapeutics..

Mesoblast Limited (MESO) Stock Analysis: Exploring a 109.83% Potential Upside

Mesoblast Limited (NASDAQ: MESO), an innovative player in the biotechnology sector, is making waves with its regenerative medicine products. Headquartered in Melbourne, Australia, the company is..

AdaptHealth Corp. (AHCO) Stock Analysis: A 30% Upside Potential Offers an Attractive Opportunity

AdaptHealth Corp. (NASDAQ: AHCO), a key player in the healthcare sector specializing in medical devices, presents a compelling investment proposition. With a market capitalization of $1.39..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Evaluating a Potential 105% Upside in the Biotech Sector

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is making waves in the biotechnology industry with its robust integration of technology and biology aimed at revolutionizing drug discovery. With..

Immunocore Holdings plc (IMCR) Stock Analysis: Significant Upside Potential with a 102% Gain on the Horizon

Immunocore Holdings plc (NASDAQ: IMCR) stands out in the biotechnology sector with its innovative approach to developing immunotherapies for cancer, infectious, and autoimmune diseases. With a..

ICU Medical, Inc. (ICUI) Stock Analysis: Investors Eye 20% Upside Potential Amid Healthcare Sector Dynamics

ICU Medical, Inc. (NASDAQ: ICUI) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in San Clemente,..

Search

Funds

February 24, 2026

Search

Funds

February 24, 2026

FTSE 100

Funds